REILLY FINANCIAL ADVISORS, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
REILLY FINANCIAL ADVISORS, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$7,0000.0%2200.0%0.00%0.0%
Q3 2021$7,000
-22.2%
2200.0%0.00%0.0%
Q2 2021$9,000
-10.0%
2200.0%0.00%0.0%
Q1 2021$10,000
-16.7%
2200.0%0.00%0.0%
Q4 2020$12,000
-47.8%
220
-54.1%
0.00%
-50.0%
Q3 2020$23,000
+76.9%
479
+117.7%
0.00%0.0%
Q2 2020$13,000
+62.5%
220
+29.4%
0.00%
+100.0%
Q1 2020$8,000
-20.0%
1700.0%0.00%0.0%
Q4 2019$10,000
-47.4%
170
-46.9%
0.00%
-50.0%
Q3 2019$19,000
-9.5%
3200.0%0.00%
-33.3%
Q2 2019$21,000
-19.2%
3200.0%0.00%0.0%
Q1 2019$26,000
+52.9%
3200.0%0.00%
+50.0%
Q4 2018$17,000
-37.0%
320
-38.5%
0.00%
-50.0%
Q3 2018$27,000
+22.7%
5200.0%0.00%
+33.3%
Q2 2018$22,000
-4.3%
5200.0%0.00%0.0%
Q1 2018$23,000
-11.5%
5200.0%0.00%
-25.0%
Q4 2017$26,0000.0%5200.0%0.00%0.0%
Q3 2017$26,0000.0%5200.0%0.00%0.0%
Q2 2017$26,000
+23.8%
5200.0%0.00%
+33.3%
Q1 2017$21,000
-16.0%
5200.0%0.00%
-25.0%
Q4 2016$25,000
+31.6%
5200.0%0.00%
+33.3%
Q3 2016$19,000
+58.3%
5200.0%0.00%
+50.0%
Q2 2016$12,000
-42.9%
5200.0%0.00%
-50.0%
Q1 2016$21,000
-34.4%
5200.0%0.00%
-33.3%
Q4 2015$32,0005200.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders